1 Garrido MM, Prigerson HG, Penrod JD, Jones SC, Boockvar KS. Benzodiazepine and sedative-hypnotic use among older seriously ill veterans: choosing wisely? Clin Ther. 2014;36(11):1547–54.
2 Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716–24.
3 Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. 2011;28(1):7–20.
4 Bavamian S, Gabutti L, Kherad O, Rondoni N, Rutishauser J, et al. Smarter Medicine: Top-5-Liste für den Spitalbereich. Swiss Medical Forum. 2016;16(32):626–9.
5 Martinsson G, Fagerberg I, Wiklund-Gustin L, Lindholm C. Specialist prescribing of psychotropic drugs to older persons in Sweden –a register-based study of 188 024 older persons. BMC Psychiatry. 2012;12:197.
6 Preville M, Vasiliadis HM, Bosse C, Dionne PA, Voyer P, Brassard J, et al. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: Results from the longitudinal ESA study. Can J Psychiatry. 2011;56:348–57.
7 Lechevallier-Michel N, Berr C, Fourrier-Réglat A. Incidence and characteristics of benzodiazepine use in an elderly cohort:
the EVA study. Therapie. 2005;60(6):561–6.
8 Tu K, Mamdani MM, Hux JE, Tu JB. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49(10):1341–5.
9 Holm E, Fosbol E, Pedersen H, Jensen TB, Nielsen M, Weeke P, et al. Benzodiazepine use in Denmark 1997–2008. Eur Geriatr Med. 2012;3(5):299–303.
10 Cloos JM, Bocquet V, Rolland-Portal I, Koch P, Chouinard G. Hypnotics and triazolobenzodiazepines – best predictors of high dose benzodiazepine use: results from the Luxembourg national health insurance registry. Psychother Psychosom. 2015;84(5):273–83.
11 Zint K, Haefeli WE, Glynn RJ, et al. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010;19:1248–55.
12 Bourin M. The problems with the use of benzodiazepines in elderly patients. Encéphale. 2010;36(4):340–7.
13 Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204(2):98–107.
14 Cantopher T, Olivieri S, Cleave N, Edwards JG. Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. Br J Psychiatry. 1990;156:406–11.
15 Gray S, Lai K, Larson E. Drug- induced cognition disorders in the elderly. Drug Safety. 1999;21:101–22.
16 Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;27:345.
17 Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009;4;9:20.
18 Luijendijk HJ, Tiemeier H, Hofman A, Heeringa J, Stricker BH. Determinants of chronic benzodiazepine use in the elderly: a longitudinal study. Br J Clin Pharmacol. 2008;65(4):593–9.
19 Jørgensen VRK. Benzodiazepine reduction in general practice. Are the elderly neglected? J Affect Disord. 2011;136(3):1216–21.
20 OECD Health Statistics 2015,http://dx.doi.org/10.1787/health-data-en.